Article Information
History
- April 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Ada Alice Dona1,2,
- Enrico Caserta1,2,
- Mahmoud Singer1,2,
- Theophilus Tandoh1,2,
- Lokesh Nigam1,2,
- Janet Winchester1,2,
- Arnab Chowdhury1,3,
- Yinghui Zhu1,2,
- Mariam Murtadha1,2,
- Alex Pozhitkov1,2,
- James F Sanchez1,
- Hawa Vahed1,2,
- Matt Coffey4,
- Guido Marcucci2,
- Amrita Krishnan1,
- Gerard Nuovo5,
- Douglas W. Sborov6,*,
- Craig C Hofmeister7,* and
- Flavia Pichiorri1,2,*
- 1Judy and Bernard Briskin Center for Multiple Myeloma Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope; Duarte, CA, USA
- 2Department of Hematologic Malignancies Translational Science, Beckman Research Institute, City of Hope; Duarte, CA, USA
- 3Department of Computational and Quantitative Medicine, Beckman Research Institute, City of Hope; Duarte, CA, USA
- 4Oncolytics Biotech, Inc.; Calgary, Canada
- 5Phylogeny Medical Laboratory; Powell, OH, USA
- 6Division of Hematology and Hematologic Malignancies, University of Utah - Huntsman Cancer Institute; Salt Lake City, UT, USA
- 7Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University; Atlanta, GA, USA
- ↵*Corresponding authors: Flavia Pichiorri, fpichiorri{at}coh.org; Craig C Hofmeister, craig.hofmeister{at}emory.edu, Douglas W. Sborov, douglas.sborov{at}hci.utah.edu.